Levodropropizine
CAS No. 99291-25-5
Levodropropizine ( Levodropropizine; DF 526; DF-526; DF526; Levotuss )
Catalog No. M16909 CAS No. 99291-25-5
Levodropropizine is a histamine receptor inhibitor, Levodropropizine is an effective and very well tolerated peripheral antitussive drug.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
1G | 38 | In Stock |
|
Biological Information
-
Product NameLevodropropizine
-
NoteResearch use only, not for human use.
-
Brief DescriptionLevodropropizine is a histamine receptor inhibitor, Levodropropizine is an effective and very well tolerated peripheral antitussive drug.
-
DescriptionLevodropropizine is a histamine receptor inhibitor, Levodropropizine is an effective and very well tolerated peripheral antitussive drug.
-
SynonymsLevodropropizine; DF 526; DF-526; DF526; Levotuss
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorHT
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number99291-25-5
-
Formula Weight236.31
-
Molecular FormulaC13H20N2O2
-
Purity>98%(HPLC)
-
SolubilityEthanol: 47 mg/mL (198.89 mM); Water: 15 mg/mL (63.47 mM); DMSO: 47 mg/mL (198.89 mM)
-
SMILESOC[C@@H](O)CN1CCN(C2=CC=CC=C2)CC1
-
Chemical Name(S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Melillo G, et al. Arzneimittelforschung, 1988, 38(8), 1144-1150.
molnova catalog
related products
-
AVN-322 free base
A highly selective, potent, BBB penetrant and orally bioavailable 5-HT6R antagonist for the treatment of neurological disorders such as AD and schizophrenia.
-
Strictosidinic acid
Strictosidinic acid, an orally active glycoside indole monoterpene alkaloid isolated from Psychotria myriantha leaves, inhibits precursor enzymes of 5-HT biosynthesis and reduces the 5-HT levels.
-
PF-04995274
PF-04995274 (TBPT) is a novel potent, sellective, partial agonist of 5-HT4 receptor under investigation for neurological disorders.